Literature DB >> 22022191

Psychometric characteristics of the Korean version of the Roland-Morris Disability Questionnaire.

Jeeyoun Moon1, Yong Chul Kim, Soo Young Park, Sang Chul Lee, Seung Pyo Choi, Francis Sahngun Nahm, Pyung Bok Lee, Eui Kyung Goo, Jong-Man Kang.   

Abstract

The aims of this study were; 1) to develop the final version of the Korean Roland-Morris Disability Questionnaire (RDQ), and 2) to compare the responsiveness between the RDQ and the Oswestry Disability Index (ODI) scores in patients having low back pain. The psychometric properties of the final Korean RDQ were evaluated in 221 patients. Among them, 30 patients were reliability tested. Validity was evaluated using an 11-point numerical rating scale (NRS) and the Korean ODI. The receiver operating characteristic (ROC) curve analysis of the RDQ and the ODI was compared in 54 patients with lumbar zygapophyseal (facet) joint pain. There was a moderate relationship between the RDQ and NRS (r = 0.59, P < 0.01) and a strongly positive correlation between the RDQ and the ODI (r = 0.76, P < 0.001). The Korean RDQ with the higher area under the ROC curve showed a better overall responsive performance than did the ODI in patients with lumbar facet joint pain after medial branch radiofrequency neurotomy (P < 0.01). The results of the study present the final version of the Korean RDQ is valid for assessing functional status in a Korean population with chronic low back pain.

Entities:  

Keywords:  Low Back Pain; Oswestry Disability Index; Psychometric Properties; Roland-Morris Disability Questionnaire

Mesh:

Year:  2011        PMID: 22022191      PMCID: PMC3192350          DOI: 10.3346/jkms.2011.26.10.1364

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  24 in total

Review 1.  Epidemiological features of chronic low-back pain.

Authors:  G B Andersson
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

2.  Active therapy for chronic low back pain: part 3. Factors influencing self-rated disability and its change following therapy.

Authors:  A F Mannion; A Junge; S Taimela; M Müntener; K Lorenzo; J Dvorak
Journal:  Spine (Phila Pa 1976)       Date:  2001-04-15       Impact factor: 3.468

3.  Validation of the Korean version of the oswestry disability index.

Authors:  Dong-Yun Kim; Sang-Ho Lee; Ho-Yeon Lee; Hyun-Ju Lee; Sang-Beom Chang; Sang-Ki Chung; Hyun-Jib Kim
Journal:  Spine (Phila Pa 1976)       Date:  2005-03-01       Impact factor: 3.468

4.  Quality criteria were proposed for measurement properties of health status questionnaires.

Authors:  Caroline B Terwee; Sandra D M Bot; Michael R de Boer; Daniëlle A W M van der Windt; Dirk L Knol; Joost Dekker; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2006-08-24       Impact factor: 6.437

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Assessing change over time in patients with low back pain.

Authors:  P W Stratford; J Binkley; P Solomon; C Gill; E Finch
Journal:  Phys Ther       Date:  1994-06

7.  Comprasion of Effectiveness of CT vs C-arm Guided Percutaneous Radiofrequency Lumbar Facet Rhizotomy.

Authors:  Chan Hong Park
Journal:  Korean J Pain       Date:  2010-05-31

8.  Responsiveness of functional status in low back pain: a comparison of different instruments.

Authors:  A J H M Beurskens; H C W de Vet; A J A Köke
Journal:  Pain       Date:  1996-04       Impact factor: 6.961

9.  Subacute and chronic low back pain. Reliability and validity of a Swedish version of the Roland and Morris Disability Questionnaire.

Authors:  E Johansson; P Lindberg
Journal:  Scand J Rehabil Med       Date:  1998-09

10.  The Quebec Back Pain Disability Scale. Measurement properties.

Authors:  J A Kopec; J M Esdaile; M Abrahamowicz; L Abenhaim; S Wood-Dauphinee; D L Lamping; J I Williams
Journal:  Spine (Phila Pa 1976)       Date:  1995-02-01       Impact factor: 3.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.